After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Regenxbio Inc is $700.12M. A total of 1.38 million shares were traded on the day, compared to an average of 596.89K shares.
In the most recent transaction, Simpson Curran sold 20,811 shares of RGNX for 12.62 per share on Oct 09 ’25. After the transaction, the Chief Executive Officer now owns 216,162 company shares. In a previous transaction on Oct 09 ’25, CURRAN M SIMPSON bought 20,811 shares at 12.22 per share.
Among the insiders who sold shares, Simpson Curran disposed of 7,624 shares on Sep 29 ’25 at a per-share price of $10.03. This resulted in the Chief Executive Officer holding 236,973 shares of RGNX after the transaction. In another insider transaction, Simpson Curran sold 7,734 shares at $10.02 per share on Sep 10 ’25. Company shares held by the Chief Executive Officer now total 244,597.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RGNX has a high of $14.24 and a low of $5.03.
As of this writing, RGNX has an earnings estimate of -$0.8 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of $0.78 per share and a lower estimate of -$1.65. The company reported an EPS of -$1.01 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RGNX’s latest balance sheet shows that the firm has $457.44M in Cash & Short Term Investments as of fiscal 2021. There were $86.68M in debt and $130.47M in liabilities at the time. Its Book Value Per Share was $3.19, while its Total Shareholder’s Equity was $764.30M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RGNX is Buy with a score of 4.50.
